EmCell Cell Therapy Center in Kyiv, Ukraine, provides specialized regenerative treatment for asthma. The clinic uses patented fetal stem cell therapy developed over 30 years of clinical experience. This approach aims to reduce chronic inflammation and help regenerate lung tissue for better respiratory health.
The primary treatment method at the clinic involves a proprietary suspension of fetal stem cells. These cells are administered through intravenous and subcutaneous injections. The procedure helps patients breathe easier and reduces persistent coughing. Many patients report a higher tolerance for exercise and physical activity after the sessions.
EmCell holds an ISO 15189 accreditation and operates a biotechnological laboratory that follows GMP standards. The center is licensed by the Ministry of Health of Ukraine and manages a large cryobank. This storage facility contains 20,000+ stem cell samples for various medical applications. The clinic specialized in lung disease treatment for over 30 years, creating personalized plans for each case.
To assist international patients, the clinic provides specific travel and communication services. These benefits make the journey to Kyiv more manageable for those seeking advanced cell therapy. Patients receive a full medical evaluation before treatment starts and follow-up care after the procedure.
You can learn more about these regenerative options or request a consultation through Bookimed.
Individual treatment program and cost estimate
Average answering time – 5 minutes
EmCell is recognized as the world’s first clinic to specialize in fetal stem cell therapy. With more than 30 years of clinical experience, the center has developed effective treatment protocols for conditions such as autism, diabetes, neurodegenerative disorders, and anti-aging. It began its work with treating aplastic anemia and continues expanding its expertise in regenerative medicine.
EmCell’s clinical department is led by medical doctors who were instrumental in developing the clinic’s patented fetal stem cell therapy. The team includes experienced neurologists, cardiologists, and general physicians, supported by skilled nurses and assistants. Comprehensive diagnostic evaluations—including ultrasound, ECG, EchoCG, Doppler studies, spirography, and densitometry—are conducted before treatment, followed by careful post-treatment monitoring to ensure safety and effectiveness.
The laboratory complex features a GMP-compliant Biotechnological Laboratory where fetal stem cell preparations are created using proprietary techniques. These preparations serve as the foundation of EmCell’s therapeutic programs. The department rigorously tests all materials throughout each stage, from donor screening to final release, to meet strict quality standards.
The PCR Laboratory performs real-time polymerase chain reaction testing to detect viral and bacterial pathogens such as HIV, HCV, HBV, CMV, HPV, and COVID-19, ensuring the safety of stem cell materials. EmCell also operates an ISO 15189-accredited Clinical-Diagnostic Laboratory offering a wide range of tests, including immunophenotyping, biochemical analysis, cytology, and hormone profiling.
The clinic maintains a cryobank housing over 20,000 live fetal stem cell samples preserved through advanced cryopreservation methods. This resource enables personalized treatment approaches and supports consistent clinical outcomes.
EmCell’s R&D division is dedicated to improving the efficacy of fetal stem cell therapies and expanding treatment options through continuous innovation and product development.
The clinic provides comprehensive patient support throughout the treatment journey. Each treatment package includes pick-up services from train or bus stations in Kyiv, daily transfers between the hotel and clinic, and interpreter support to facilitate clear communication with the medical team. Patients also undergo a series of examinations, such as abdominal and thyroid ultrasounds, ECG, and laboratory tests.
Following treatment, EmCell maintains long-term communication with each patient. A dedicated follow-up manager and the treating physician remain available to answer questions, provide additional recommendations, and track post-treatment progress.
Individual treatment program and cost estimate
Average answering time – 5 minutes